In a move expected to save the health system $12 million, New Hyde Park, N.Y.-based Northwell Health will move its pharmacy and delivery service in-house for its 66,000 employees, according to a Newsday report.
Pharmacy
CVS Health fired a pharmacist who would not fill a transgender woman's hormone prescription April 24 at a pharmacy in Phoenix, according to USA Today.
Medicare patients could often spend less on prescriptions filled through Walmart's generic drug discount program than through their own insurance plan, according to research from New Haven, Conn.-based Yale School of Medicine.
AstraZeneca will not raise the price of its medications in 2018, joining the ranks of numerous drug companies changing their pricing strategies after scrutiny from President Donald Trump, reports Reuters.
Biopharmaceutical company Gilead Sciences' President and CEO John F. Milligan, PhD, is stepping down by 2019, the company said July 25.
Humana's pharmacy business is the fourth-largest pharmacy benefits manager in the U.S., filling 433 million prescriptions last year, according to an Insider Louisville report.
Embattled OxyContin maker Purdue Pharma hired Steve Miller, a famous figure in corporate restructuring, to head its board as the drugmaker seeks to overhaul its business and distance itself from the U.S. opioid crisis, Bloomberg reports.
A proposed policy threatening to overhaul safe harbor protections for pharmaceutical company rebates, which largely benefits pharmacy benefit managers, sent shares of the PBMs sliding July 19, according to MarketWatch.
The Trump administration is considering a proposal that will remove or alter safe harbor protections for pharmaceutical company rebates — a plan that could reshape how prescription drugs are priced and sold, according to The Wall Street Journal.
Merck became the first drugmaker to voluntarily lower the costs of several drugs after President Donald Trump called out the pharmaceutical industry for raising prices and failing to make healthcare affordable for patients, according to Reuters.